BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

278 related articles for article (PubMed ID: 18701085)

  • 1. Posttranscriptional regulation of II10 gene expression allows natural killer cells to express immunoregulatory function.
    Maroof A; Beattie L; Zubairi S; Svensson M; Stager S; Kaye PM
    Immunity; 2008 Aug; 29(2):295-305. PubMed ID: 18701085
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An in vivo analysis of cytokine production during Leishmania donovani infection in scid mice.
    Engwerda CR; Smelt SC; Kaye PM
    Exp Parasitol; 1996 Nov; 84(2):195-202. PubMed ID: 8932769
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Critical role of IRF-5 in the development of T helper 1 responses to Leishmania donovani infection.
    Paun A; Bankoti R; Joshi T; Pitha PM; Stäger S
    PLoS Pathog; 2011 Jan; 7(1):e1001246. PubMed ID: 21253574
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Granzyme-mediated regulation of host defense in the liver in experimental Leishmania donovani infection.
    Murray HW; Mitchell-Flack M; Zheng H; Ma X
    Infect Immun; 2015 Feb; 83(2):702-12. PubMed ID: 25452549
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Regulatory actions of Toll-like receptor 2 (TLR2) and TLR4 in Leishmania donovani infection in the liver.
    Murray HW; Zhang Y; Zhang Y; Raman VS; Reed SG; Ma X
    Infect Immun; 2013 Jul; 81(7):2318-26. PubMed ID: 23589575
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Splenic accumulation of IL-10 mRNA in T cells distinct from CD4+CD25+ (Foxp3) regulatory T cells in human visceral leishmaniasis.
    Nylén S; Maurya R; Eidsmo L; Manandhar KD; Sundar S; Sacks D
    J Exp Med; 2007 Apr; 204(4):805-17. PubMed ID: 17389235
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Complete protection against experimental visceral leishmaniasis with complete soluble antigen from attenuated Leishmania donovani promastigotes involves Th1-immunity and down-regulation of IL-10.
    Bhaumik SK; Naskar K; De T
    Eur J Immunol; 2009 Aug; 39(8):2146-60. PubMed ID: 19593771
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevention of relapse after chemotherapy in a chronic intracellular infection: mechanisms in experimental visceral leishmaniasis.
    Murray HW
    J Immunol; 2005 Apr; 174(8):4916-23. PubMed ID: 15814719
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Distinct Roles for CD4
    Bunn PT; Montes de Oca M; de Labastida Rivera F; Kumar R; Ng SS; Edwards CL; Faleiro RJ; Sheel M; Amante FH; Frame TCM; Muller W; Haque A; Uzonna JE; Hill GR; Engwerda CR
    J Immunol; 2018 Dec; 201(11):3362-3372. PubMed ID: 30355785
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Leishmania donovani skews the CD56(+) Natural Killer T cell response during human visceral leishmaniasis.
    Kumari S; Jamal F; Shivam P; Thakur A; Kumar M; Bimal S; Das VN; Pandey K; Narayan S; Gupta AK; Das P; Singh SK
    Cytokine; 2015 May; 73(1):53-60. PubMed ID: 25697139
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Petri net model of granulomatous inflammation: implications for IL-10 mediated control of Leishmania donovani infection.
    Albergante L; Timmis J; Beattie L; Kaye PM
    PLoS Comput Biol; 2013; 9(11):e1003334. PubMed ID: 24363630
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hybrid cell vaccination resolves Leishmania donovani infection by eliciting a strong CD8+ cytotoxic T-lymphocyte response with concomitant suppression of interleukin-10 (IL-10) but not IL-4 or IL-13.
    Basu R; Bhaumik S; Haldar AK; Naskar K; De T; Dana SK; Walden P; Roy S
    Infect Immun; 2007 Dec; 75(12):5956-66. PubMed ID: 17908806
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The IL-33/ST2 axis is associated with human visceral leishmaniasis and suppresses Th1 responses in the livers of BALB/c mice infected with Leishmania donovani.
    Rostan O; Gangneux JP; Piquet-Pellorce C; Manuel C; McKenzie AN; Guiguen C; Samson M; Robert-Gangneux F
    mBio; 2013 Sep; 4(5):e00383-13. PubMed ID: 24045639
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Activation of invariant NKT cells exacerbates experimental visceral leishmaniasis.
    Stanley AC; Zhou Y; Amante FH; Randall LM; Haque A; Pellicci DG; Hill GR; Smyth MJ; Godfrey DI; Engwerda CR
    PLoS Pathog; 2008 Feb; 4(2):e1000028. PubMed ID: 18463695
    [TBL] [Abstract][Full Text] [Related]  

  • 15. STAT4 is critical for immunity but not for antileishmanial activity of antimonials in experimental visceral leishmaniasis.
    Oghumu S; Gupta G; Snider HM; Varikuti S; Terrazas CA; Papenfuss TL; Kaplan MH; Satoskar AR
    Eur J Immunol; 2014 Feb; 44(2):450-9. PubMed ID: 24242758
    [TBL] [Abstract][Full Text] [Related]  

  • 16. TLR-mediated distinct IFN-γ/IL-10 pattern induces protective immunity against murine visceral leishmaniasis.
    Paul J; Karmakar S; De T
    Eur J Immunol; 2012 Aug; 42(8):2087-99. PubMed ID: 22622993
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Splenic CD4+ T Cells in Progressive Visceral Leishmaniasis Show a Mixed Effector-Regulatory Phenotype and Impair Macrophage Effector Function through Inhibitory Receptor Expression.
    Medina-Colorado AA; Osorio EY; Saldarriaga OA; Travi BL; Kong F; Spratt H; Soong L; Melby PC
    PLoS One; 2017; 12(1):e0169496. PubMed ID: 28103263
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Leishmania donovani infection initiates T cell-independent chemokine responses, which are subsequently amplified in a T cell-dependent manner.
    Cotterell SE; Engwerda CR; Kaye PM
    Eur J Immunol; 1999 Jan; 29(1):203-14. PubMed ID: 9933102
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Innate immune defense in visceral leishmaniasis: cytokine mediated protective role by allogeneic effector cell.
    Manna PP; Chakrabarti G; Bandyopadhyay S
    Vaccine; 2010 Jan; 28(3):803-10. PubMed ID: 19879234
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Involvement of CD4⁺ Foxp3⁺ regulatory T cells in persistence of Leishmania donovani in the liver of alymphoplastic aly/aly mice.
    Tiwananthagorn S; Iwabuchi K; Ato M; Sakurai T; Kato H; Katakura K
    PLoS Negl Trop Dis; 2012; 6(8):e1798. PubMed ID: 22928057
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.